Back to quiz

6. Adenoleukodystrophy mainly affects which part of the body?

  • Lymphatic system
  • Thymus
  • White matter
  • White blood cells

7. ‘Gowers sign’ is the typical clinical indication of which disease?

  • Epilepsy
  • Gaucher’s disease
  • Muscular dystrophy
  • Parkinson’s

8. ‘Gene silencing’ is a new technique being developed as a potential therapeutic to which disease?

  • Peripheral nerve degeneration
  • Huntington’s disease
  • Adrenoleukodystrophy
  • Idiopathic Parkinson’s disease

9. Gauncher Mutation is a risk factor of Parkinson’s disease

  • True
  • False

10. Non Poly-Q disease also involves repeats of CAG nucleotides

  • False - They involve any other triplet except CAG
  • True - They give rise to similar disorders

11. Which diseases can mimic the clinical presentation found in Idiopathic Parkinson’s?

  • Multiple System Atrophy & Progressive Supranuclear Gaze Palsy
  • Epilepsy & Bell’s Palsy
  • Gauncher’s Disease & Myotonic Dystrophy
  • Hypercholesterolaemia & Myositis Ossificans & Creutzfeldt

12. Trinucleotide repeat disorders are usually formed during mitosis

  • False
  • True

13. What diseases are a result of CAG nucleotide repeat expansions?

  • Huntington’s disease
  • Fragile-X syndrome
  • Friedriech’s ataxia

14. What best describes ‘Anticipation’

  • Single point-mutation error that only shows phenotype in 50% of individuals
  • Expansion of the trinucleotide region causing severe phenotype in subsequent generations
  • Deletion of the trinucleotide region, presenting phenotype only in the previous generation
  • Duplication of a specific triplet nucleotide that causes late onset in adult life

15. Common manifestations of mitochondrial disease

  • Myasthenia gravis, Adrenoleukodystrophy, Alkalosis
  • Myopathy, Encephalopathy, Diabetes
  • Mucopolysaccharidoses, Anti-trypsin deficiency, Phenylketonuria

16. ‘Premature degeneration’ is associated with which of the following?

  • Toxic gain of function
  • Total dysfunction
  • Insufficient gain of function
  • Intermittent function

17. What is the typical mode of inheritance of Poly-Q disease?

  • Mitochondrial
  • Autosomal Dominant
  • X-Linked Recessive
  • Autosomal Recessive

18. How does ‘gene silencing’ work?

  • Sense polynucleotides in reverse sequences to DNA/RNA
  • Anti-sense oligonucleotides in reverse sequences to DNA/RNA
  • Sense oligonucleotides in reverse sequences to DNA/RNA
  • Anti-sense polynucleotides in reverse sequences to DNA/RNA

19. Huntington’s disease is not associated with haploinsufficiency, why?

  • It only occurs in Fragile-X Syndrome
  • Huntington’s is a toxic gain of function
  • It is non-compatible with life
  • Huntington’s is a diploinsufficiency

20. Why are some genetic disorders not considered to be ‘congenital’

  • Gene products involved in functions that are not apparent at birth
  • Most congenital disorders result in sporadic abortion
  • Mutations have not occurred in utero, but during development
  • Mutations have occurred as a result of environmental factors